Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates

Buddy Ullman, Darrick Carter

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

All genera of protozoan parasites are auxotrophic for purines, and thus, purine acquisition from the host is a nutritional necessity for the survival and growth of these pathogens. Many of these parasites, including Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp., access host purines by phosphoribosylating purine bases via purine phosphoribosyltransferase (PRT) enzymes. The trypanosomatid hypoxanthine-guanine phosphoribosyltransferase (HGPRT) enzyme has been implicated as a critical enzyme of purine salvage in members of the Trypanosomatidae family. Moreover, the HGPRT enzymes of Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. can also initiate the metabolism of certain cytotoxic purine base analogs that have little effect on the mammalian host. This implies that either inhibitors or substrates of HGPRT might serve as efficacious and selective agents for the treatment of diseases for which trypanosomatids are the etiologic agent. The hgprt genes from Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani have all been cloned, sequenced and overexpressed in E. coli, and the recombinant proteins have all been purified to homogeneity and characterized with respect to kinetic parameters and physicochemical properties. This paper presents an overview of recent molecular and biochemical studies on trypanosomatid HGPRT proteins and future efforts to validate HGPRT as a rational target for the chemotherapeutic manipulation of African sleeping sickness, Chagas disease and leishmaniasis.

Original languageEnglish (US)
Pages (from-to)203-213
Number of pages11
JournalInternational Journal for Parasitology
Volume27
Issue number2
DOIs
StatePublished - Feb 1997

Fingerprint

Hypoxanthine Phosphoribosyltransferase
Trypanosoma brucei brucei
Trypanosoma cruzi
Purines
Leishmania
Enzymes
Parasites
Trypanosomatina
African Trypanosomiasis
Leishmania donovani
Leishmaniasis
Chagas Disease
Escherichia coli Proteins
Recombinant Proteins
purine
Growth
Genes
Proteins

Keywords

  • biochemistry
  • chemotherapy
  • hypoxanthine-guanine phosphoribosyltransferase
  • Leishmania
  • molecular biology
  • puri nes
  • structural biology
  • trypanosomatids
  • trypanosomes

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Cite this

Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates. / Ullman, Buddy; Carter, Darrick.

In: International Journal for Parasitology, Vol. 27, No. 2, 02.1997, p. 203-213.

Research output: Contribution to journalArticle

@article{4118e12179354ae9b2e33e2d71b480fa,
title = "Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates",
abstract = "All genera of protozoan parasites are auxotrophic for purines, and thus, purine acquisition from the host is a nutritional necessity for the survival and growth of these pathogens. Many of these parasites, including Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp., access host purines by phosphoribosylating purine bases via purine phosphoribosyltransferase (PRT) enzymes. The trypanosomatid hypoxanthine-guanine phosphoribosyltransferase (HGPRT) enzyme has been implicated as a critical enzyme of purine salvage in members of the Trypanosomatidae family. Moreover, the HGPRT enzymes of Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. can also initiate the metabolism of certain cytotoxic purine base analogs that have little effect on the mammalian host. This implies that either inhibitors or substrates of HGPRT might serve as efficacious and selective agents for the treatment of diseases for which trypanosomatids are the etiologic agent. The hgprt genes from Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani have all been cloned, sequenced and overexpressed in E. coli, and the recombinant proteins have all been purified to homogeneity and characterized with respect to kinetic parameters and physicochemical properties. This paper presents an overview of recent molecular and biochemical studies on trypanosomatid HGPRT proteins and future efforts to validate HGPRT as a rational target for the chemotherapeutic manipulation of African sleeping sickness, Chagas disease and leishmaniasis.",
keywords = "biochemistry, chemotherapy, hypoxanthine-guanine phosphoribosyltransferase, Leishmania, molecular biology, puri nes, structural biology, trypanosomatids, trypanosomes",
author = "Buddy Ullman and Darrick Carter",
year = "1997",
month = "2",
doi = "10.1016/S0020-7519(96)00150-6",
language = "English (US)",
volume = "27",
pages = "203--213",
journal = "International Journal for Parasitology",
issn = "0020-7519",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates

AU - Ullman, Buddy

AU - Carter, Darrick

PY - 1997/2

Y1 - 1997/2

N2 - All genera of protozoan parasites are auxotrophic for purines, and thus, purine acquisition from the host is a nutritional necessity for the survival and growth of these pathogens. Many of these parasites, including Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp., access host purines by phosphoribosylating purine bases via purine phosphoribosyltransferase (PRT) enzymes. The trypanosomatid hypoxanthine-guanine phosphoribosyltransferase (HGPRT) enzyme has been implicated as a critical enzyme of purine salvage in members of the Trypanosomatidae family. Moreover, the HGPRT enzymes of Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. can also initiate the metabolism of certain cytotoxic purine base analogs that have little effect on the mammalian host. This implies that either inhibitors or substrates of HGPRT might serve as efficacious and selective agents for the treatment of diseases for which trypanosomatids are the etiologic agent. The hgprt genes from Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani have all been cloned, sequenced and overexpressed in E. coli, and the recombinant proteins have all been purified to homogeneity and characterized with respect to kinetic parameters and physicochemical properties. This paper presents an overview of recent molecular and biochemical studies on trypanosomatid HGPRT proteins and future efforts to validate HGPRT as a rational target for the chemotherapeutic manipulation of African sleeping sickness, Chagas disease and leishmaniasis.

AB - All genera of protozoan parasites are auxotrophic for purines, and thus, purine acquisition from the host is a nutritional necessity for the survival and growth of these pathogens. Many of these parasites, including Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp., access host purines by phosphoribosylating purine bases via purine phosphoribosyltransferase (PRT) enzymes. The trypanosomatid hypoxanthine-guanine phosphoribosyltransferase (HGPRT) enzyme has been implicated as a critical enzyme of purine salvage in members of the Trypanosomatidae family. Moreover, the HGPRT enzymes of Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. can also initiate the metabolism of certain cytotoxic purine base analogs that have little effect on the mammalian host. This implies that either inhibitors or substrates of HGPRT might serve as efficacious and selective agents for the treatment of diseases for which trypanosomatids are the etiologic agent. The hgprt genes from Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani have all been cloned, sequenced and overexpressed in E. coli, and the recombinant proteins have all been purified to homogeneity and characterized with respect to kinetic parameters and physicochemical properties. This paper presents an overview of recent molecular and biochemical studies on trypanosomatid HGPRT proteins and future efforts to validate HGPRT as a rational target for the chemotherapeutic manipulation of African sleeping sickness, Chagas disease and leishmaniasis.

KW - biochemistry

KW - chemotherapy

KW - hypoxanthine-guanine phosphoribosyltransferase

KW - Leishmania

KW - molecular biology

KW - puri nes

KW - structural biology

KW - trypanosomatids

KW - trypanosomes

UR - http://www.scopus.com/inward/record.url?scp=0031080430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031080430&partnerID=8YFLogxK

U2 - 10.1016/S0020-7519(96)00150-6

DO - 10.1016/S0020-7519(96)00150-6

M3 - Article

VL - 27

SP - 203

EP - 213

JO - International Journal for Parasitology

JF - International Journal for Parasitology

SN - 0020-7519

IS - 2

ER -